{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:24:37Z","timestamp":1777350277998,"version":"3.51.4"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 106-2314-B-038-030"],"award-info":[{"award-number":["MOST 106-2314-B-038-030"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 108-2314-B-075-049-MY3"],"award-info":[{"award-number":["MOST 108-2314-B-075-049-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-050"],"award-info":[{"award-number":["V108C-050"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V109C-154"],"award-info":[{"award-number":["V109C-154"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V107D36-003-MY2-2"],"award-info":[{"award-number":["V107D36-003-MY2-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["VGHUST109-V6-2-2"],"award-info":[{"award-number":["VGHUST109-V6-2-2"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["Center of Excellence for Cancer Research MOHW109-TDU-B-211-134019"],"award-info":[{"award-number":["Center of Excellence for Cancer Research MOHW109-TDU-B-211-134019"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["Big Data Center"],"award-info":[{"award-number":["Big Data Center"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>There has been insufficient investigation of the differences in long-term outcomes between surgical resection (SR) and radiofrequency ablation (RFA) among patients with hepatocellular carcinoma (HCC) and esophagogastric varices (EGV). We retrospectively enrolled 251 patients with treatment-na\u00efve HCC and EGV who underwent SR or RFA as a first-line treatment. Prognostic factors were analyzed using a Cox proportional hazards model. A total of 68 patients underwent SR, and the remaining 183 patients received RFA. Patients who underwent SR were younger, had better liver functional reserves, and had larger tumors. After a median follow-up duration of 45.1\u00a0months, 151 patients died. The cumulative 5-year overall survival (OS) rate was significantly higher among patients who underwent SR than those treated with RFA (66.7% vs. 36.8%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Multivariate analysis showed that age\u2009&gt;\u200965\u00a0years, multiple tumors, RFA, albumin bilirubin grade\u2009&gt;\u20091, and the occurrence of major peri-procedural morbidity were the independent risk factors that are predictive of poor OS. In conclusion, SR could be recommended as a first-line treatment modality for HCC patients with EGV if the patients are carefully selected and liver function is well preserved.<\/jats:p>","DOI":"10.1038\/s41598-020-74424-y","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T10:04:52Z","timestamp":1602669892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["A comparison of prognoses between surgical resection and radiofrequency ablation therapy for patients with hepatocellular carcinoma and esophagogastric varices"],"prefix":"10.1038","volume":"10","author":[{"given":"Cheng-Yi","family":"Wei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gar-Yang","family":"Chau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping-Hsien","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-An","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hsiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teh-Ia","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chih","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Hui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3889-7004","authenticated-orcid":false,"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"key":"74424_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre, L. A. et al. Global cancer statistics, 2012. CA Cancer J. Clin. 65, 87\u2013108. https:\/\/doi.org\/10.3322\/caac.21262 (2015).","journal-title":"CA Cancer J. Clin."},{"key":"74424_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","volume":"156","author":"L Kulik","year":"2019","unstructured":"Kulik, L. & El-Serag, H. B. Epidemiology and management of hepatocellular carcinoma. Gastroenterology 156, 477\u2013491e471. https:\/\/doi.org\/10.1053\/j.gastro.2018.08.065 (2019).","journal-title":"Gastroenterology"},{"key":"74424_CR3","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/cncr.30237","volume":"122","author":"SP Choo","year":"2016","unstructured":"Choo, S. P., Tan, W. L., Goh, B. K. P., Tai, W. M. & Zhu, A. X. Comparison of hepatocellular carcinoma in Eastern versus Western populations. Cancer 122, 3430\u20133446. https:\/\/doi.org\/10.1002\/cncr.30237 (2016).","journal-title":"Cancer"},{"key":"74424_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1053\/j.gastro.2016.11.020","volume":"152","author":"DL White","year":"2017","unstructured":"White, D. L., Thrift, A. P., Kanwal, F., Davila, J. & El-Serag, H. B. Incidence of hepatocellular carcinoma in All 50 United States, from 2000 to 2012. Gastroenterology 152, 812\u2013820e815. https:\/\/doi.org\/10.1053\/j.gastro.2016.11.020 (2017).","journal-title":"Gastroenterology"},{"key":"74424_CR5","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","volume":"17","author":"Z Younossi","year":"2019","unstructured":"Younossi, Z. et al. Nonalcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin. Gastroenterol. Hepatol. 17, 748\u2013755e743. https:\/\/doi.org\/10.1016\/j.cgh.2018.05.057 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"74424_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1159\/000484619","volume":"7","author":"M Kudo","year":"2018","unstructured":"Kudo, M. Management of hepatocellular carcinoma in japan as a world-leading model. Liver Cancer 7, 134\u2013147. https:\/\/doi.org\/10.1159\/000484619 (2018).","journal-title":"Liver Cancer"},{"key":"74424_CR7","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med. 380, 1450\u20131462. https:\/\/doi.org\/10.1056\/NEJMra1713263 (2019).","journal-title":"N. Engl. J. Med."},{"key":"74424_CR8","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/gut.2004.045203","volume":"54","author":"S Lin","year":"2005","unstructured":"Lin, S., Lin, C., Lin, C., Hsu, C. & Chen, Y. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 54, 1151\u20131156 (2005).","journal-title":"Gut"},{"key":"74424_CR9","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1148\/radiol.11110144","volume":"262","author":"R Lencioni","year":"2012","unstructured":"Lencioni, R. & Crocetti, L. Local-regional treatment of hepatocellular carcinoma. Radiology 262, 43\u201358. https:\/\/doi.org\/10.1148\/radiol.11110144 (2012).","journal-title":"Radiology"},{"key":"74424_CR10","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jhep.2009.12.004","volume":"52","author":"G Germani","year":"2010","unstructured":"Germani, G. et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. J. Hepatol. 52, 380\u2013388 (2010).","journal-title":"J. Hepatol."},{"key":"74424_CR11","doi-asserted-by":"publisher","first-page":"e1929","DOI":"10.1097\/MD.0000000000001929","volume":"94","author":"WY Kao","year":"2015","unstructured":"Kao, W. Y. et al. Prognosis of early-stage hepatocellular carcinoma: the clinical implications of substages of Barcelona clinic liver cancer system based on a cohort of 1265 patients. Medicine (Baltimore) 94, e1929. https:\/\/doi.org\/10.1097\/MD.0000000000001929 (2015).","journal-title":"Medicine (Baltimore)"},{"key":"74424_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2013.03.009","volume":"59","author":"M Pompili","year":"2013","unstructured":"Pompili, M. et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma <\/=3 cm. Results of a multicenter Italian survey. J. Hepatol. 59, 89\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2013.03.009 (2013).","journal-title":"J. Hepatol."},{"key":"74424_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cgh.2010.08.018","volume":"9","author":"HH Hung","year":"2011","unstructured":"Hung, H. H. et al. Survival rates are comparable after radiofrequency ablation or surgery in patients with small hepatocellular carcinomas. Clin. Gastroenterol. Hepatol. 9, 79\u201386. https:\/\/doi.org\/10.1016\/j.cgh.2010.08.018 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"74424_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","volume":"58","author":"K Hasegawa","year":"2013","unstructured":"Hasegawa, K. et al. Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J. Hepatol. 58, 724\u2013729. https:\/\/doi.org\/10.1016\/j.jhep.2012.11.009 (2013).","journal-title":"J. Hepatol."},{"key":"74424_CR15","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/SLA.0b013e3181efc65600000658-201012000-00003[pii]","volume":"252","author":"J Huang","year":"2010","unstructured":"Huang, J. et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann. Surg. 252, 903\u2013912. https:\/\/doi.org\/10.1097\/SLA.0b013e3181efc65600000658-201012000-00003[pii] (2010).","journal-title":"Ann. Surg."},{"key":"74424_CR16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.jhep.2012.05.007","volume":"57","author":"K Feng","year":"2012","unstructured":"Feng, K. et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J. Hepatol. 57, 794\u2013802. https:\/\/doi.org\/10.1016\/j.jhep.2012.05.007 (2012).","journal-title":"J. Hepatol."},{"key":"74424_CR17","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1245\/s10434-014-4221-5","volume":"22","author":"CW Su","year":"2015","unstructured":"Su, C. W. et al. Impact of steatosis on prognosis of patients with early-stage hepatocellular carcinoma after hepatic resection. Ann. Surg. Oncol. 22, 2253\u20132261. https:\/\/doi.org\/10.1245\/s10434-014-4221-5 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"74424_CR18","doi-asserted-by":"publisher","first-page":"42577","DOI":"10.1038\/srep42577","volume":"7","author":"WY Hsieh","year":"2017","unstructured":"Hsieh, W. Y. et al. The impact of esophagogastric varices on the prognosis of patients with hepatocellular carcinoma. Sci. Rep. 7, 42577. https:\/\/doi.org\/10.1038\/srep42577 (2017).","journal-title":"Sci. Rep."},{"key":"74424_CR19","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1111\/apt.12721","volume":"39","author":"G D\u2019amico","year":"2014","unstructured":"D\u2019amico, G. et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment. Pharm. Ther. 39, 1180\u20131193 (2014).","journal-title":"Aliment. Pharm. Ther."},{"key":"74424_CR20","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.cgh.2015.07.012","volume":"13","author":"G Garcia-Tsao","year":"2015","unstructured":"Garcia-Tsao, G. & Bosch, J. Varices and variceal hemorrhage in cirrhosis: a new view of an old problem. Clin. Gastroenterol. Hepatol. 13, 2109\u20132117. https:\/\/doi.org\/10.1016\/j.cgh.2015.07.012 (2015).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"74424_CR21","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.cgh.2006.08.011","volume":"4","author":"EG Giannini","year":"2006","unstructured":"Giannini, E. G. et al. Prevalence and prognostic significance of the presence of esophageal varices in patients with hepatocellular carcinoma. Clin. Gastroenterol. Hepatol. 4, 1378\u20131384. https:\/\/doi.org\/10.1016\/j.cgh.2006.08.011 (2006).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"74424_CR22","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/S0016-5085(96)70070-7","volume":"111","author":"J Bruix","year":"1996","unstructured":"Bruix, J. et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111, 1018\u20131022 (1996).","journal-title":"Gastroenterology"},{"key":"74424_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach, J. K. et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67, 358\u2013380 (2018).","journal-title":"Hepatology"},{"key":"74424_CR24","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1002\/hep.510300629","volume":"30","author":"JM Llovet","year":"1999","unstructured":"Llovet, J. M., Fuster, J. & Bruix, J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30, 1434\u20131440 (1999).","journal-title":"Hepatology"},{"key":"74424_CR25","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/hep.27431","volume":"61","author":"A Berzigotti","year":"2015","unstructured":"Berzigotti, A., Reig, M., Abraldes, J. G., Bosch, J. & Bruix, J. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis. Hepatology 61, 526\u2013536. https:\/\/doi.org\/10.1002\/hep.27431 (2015).","journal-title":"Hepatology"},{"key":"74424_CR26","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","volume":"134","author":"T Ishizawa","year":"2008","unstructured":"Ishizawa, T. et al. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134, 1908\u20131916 (2008).","journal-title":"Gastroenterology"},{"key":"74424_CR27","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","volume":"62","author":"A Vitale","year":"2015","unstructured":"Vitale, A. et al. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona clinic liver cancer stages: a multicentre study. J. Hepatol. 62, 617\u2013624 (2015).","journal-title":"J. Hepatol."},{"key":"74424_CR28","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","volume":"257","author":"G Torzilli","year":"2013","unstructured":"Torzilli, G. et al. A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations? An observational study of the HCC East-West study group. Ann. Surg. 257, 929\u2013937 (2013).","journal-title":"Ann. Surg."},{"key":"74424_CR29","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1097\/MEG.0000000000001193","volume":"30","author":"CY Chang","year":"2018","unstructured":"Chang, C. Y. et al. Esophageal varices are not predictive of patient prognosis after surgical resection of hepatocellular carcinoma. Eur. J. Gastroenterol. Hepatol. 30, 1368\u20131377. https:\/\/doi.org\/10.1097\/MEG.0000000000001193 (2018).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"74424_CR30","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.surg.2015.04.002","volume":"158","author":"J Qiu","year":"2015","unstructured":"Qiu, J. et al. Resection versus ablation in hepatitis B virus-related hepatocellular carcinoma patients with portal hypertension: a propensity score matching study. Surgery 158, 1235\u20131243. https:\/\/doi.org\/10.1016\/j.surg.2015.04.002 (2015).","journal-title":"Surgery"},{"key":"74424_CR31","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","volume":"63","author":"R De Franchis","year":"2015","unstructured":"De Franchis, R. Expanding consensus in portal hypertension: report of the Baveno VI consensus workshop: stratifying risk and individualizing care for portal hypertension. J. Hepatol. 63, 743\u2013752 (2015).","journal-title":"J. Hepatol."},{"key":"74424_CR32","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.jfma.2019.09.003","volume":"119","author":"CW Su","year":"2020","unstructured":"Su, C. W. et al. Association between esophagogastric varices in hepatocellular carcinoma and poor prognosis after transarterial chemoembolization: a propensity score matching analysis. J. Formos. Med. Assoc. 119, 610\u2013620. https:\/\/doi.org\/10.1016\/j.jfma.2019.09.003 (2020).","journal-title":"J. Formos. Med. Assoc."},{"key":"74424_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.jhep.2015.08.025","volume":"64","author":"A Cucchetti","year":"2016","unstructured":"Cucchetti, A. et al. Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma. J. Hepatol. 64, 79\u201386. https:\/\/doi.org\/10.1016\/j.jhep.2015.08.025 (2016).","journal-title":"J. Hepatol."},{"key":"74424_CR34","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1007\/s00330-016-4604-z","volume":"27","author":"K-C Fang","year":"2017","unstructured":"Fang, K.-C. et al. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis. Eur. Radiol. 27, 2600\u20132609 (2017).","journal-title":"Eur. Radiol."},{"key":"74424_CR35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000335741","volume":"29","author":"T Schreckenbach","year":"2012","unstructured":"Schreckenbach, T., Liese, J., Bechstein, W. O. & Moench, C. Posthepatectomy liver failure. Dig. Surg. 29, 79\u201385. https:\/\/doi.org\/10.1159\/000335741 (2012).","journal-title":"Dig. Surg."},{"key":"74424_CR36","doi-asserted-by":"publisher","first-page":"2510","DOI":"10.1007\/s00268-015-3110-9","volume":"39","author":"N Harada","year":"2015","unstructured":"Harada, N. et al. Surgical resection for hepatocellular carcinoma with concomitant esophageal varices. World J Surg 39, 2510\u20132518. https:\/\/doi.org\/10.1007\/s00268-015-3110-9 (2015).","journal-title":"World J Surg"},{"key":"74424_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hep.27745","volume":"62","author":"S Roayaie","year":"2015","unstructured":"Roayaie, S. et al. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62, 440\u2013451. https:\/\/doi.org\/10.1002\/hep.27745 (2015).","journal-title":"Hepatology"},{"key":"74424_CR38","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/ajg.2011.425","volume":"107","author":"S Shiina","year":"2012","unstructured":"Shiina, S. et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am. J. Gastroenterol. 107, 569\u2013577. https:\/\/doi.org\/10.1038\/ajg.2011.425 (2012).","journal-title":"Am. J. Gastroenterol."},{"key":"74424_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2012.09.020","volume":"58","author":"YS Kim","year":"2013","unstructured":"Kim, Y. S. et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J. Hepatol. 58, 89\u201397. https:\/\/doi.org\/10.1016\/j.jhep.2012.09.020 (2013).","journal-title":"J. Hepatol."},{"key":"74424_CR40","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1148\/radiol.2017162382","volume":"285","author":"WY Kao","year":"2017","unstructured":"Kao, W. Y. et al. Hepatocellular carcinoma: nomograms based on the albumin-bilirubin grade to assess the outcomes of radiofrequency ablation. Radiology 285, 670\u2013680. https:\/\/doi.org\/10.1148\/radiol.2017162382 (2017).","journal-title":"Radiology"},{"key":"74424_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jhep.2018.02.026","volume":"69","author":"S Lee","year":"2018","unstructured":"Lee, S. et al. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: propensity score analyses of long-term outcomes. J. Hepatol. 69, 70\u201378 (2018).","journal-title":"J. Hepatol."},{"key":"74424_CR42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/archsurg.2011.288","volume":"147","author":"CW Su","year":"2012","unstructured":"Su, C. W. et al. The effect of age on the long-term prognosis of patients with hepatocellular carcinoma after resection surgery: a propensity score matching analysis. Arch. Surg. 147, 137\u2013144. https:\/\/doi.org\/10.1001\/archsurg.2011.288 (2012).","journal-title":"Arch. Surg."},{"key":"74424_CR43","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jhep.2013.04.009","volume":"59","author":"A Cucchetti","year":"2013","unstructured":"Cucchetti, A. et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J. Hepatol. 59, 300\u2013307. https:\/\/doi.org\/10.1016\/j.jhep.2013.04.009 (2013).","journal-title":"J. Hepatol."},{"key":"74424_CR44","doi-asserted-by":"publisher","first-page":"3289","DOI":"10.1245\/s10434-009-0678-z","volume":"16","author":"R Santambrogio","year":"2009","unstructured":"Santambrogio, R. et al. Surgical resection versus laparoscopic radiofrequency ablation in patients with hepatocellular carcinoma and Child-Pugh class a liver cirrhosis. Ann. Surg. Oncol. 16, 3289\u20133298 (2009).","journal-title":"Ann. Surg. Oncol."},{"key":"74424_CR45","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1053\/jhep.2000.20456","volume":"32","author":"S Arii","year":"2000","unstructured":"Arii, S. et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 32, 1224\u20131229 (2000).","journal-title":"Hepatology"},{"key":"74424_CR46","doi-asserted-by":"publisher","first-page":"2919","DOI":"10.1007\/s00268-014-2659-z","volume":"38","author":"R Memeo","year":"2014","unstructured":"Memeo, R. et al. Laparoscopic vs. open liver resection for hepatocellular carcinoma of cirrhotic liver: a case-control study. World J. Surg. 38, 2919\u20132926. https:\/\/doi.org\/10.1007\/s00268-014-2659-z (2014).","journal-title":"World J. Surg."},{"key":"74424_CR47","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.jhep.2015.04.005","volume":"63","author":"HS Han","year":"2015","unstructured":"Han, H. S. et al. Laparoscopic versus open liver resection for hepatocellular carcinoma: case-matched study with propensity score matching. J. Hepatol. 63, 643\u2013650. https:\/\/doi.org\/10.1016\/j.jhep.2015.04.005 (2015).","journal-title":"J. Hepatol."},{"key":"74424_CR48","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00464-018-6296-8","volume":"33","author":"X Wu","year":"2019","unstructured":"Wu, X. et al. Perioperative and long-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with well-preserved liver function and cirrhotic background: a propensity score matching study. Surg. Endosc. 33, 206\u2013215. https:\/\/doi.org\/10.1007\/s00464-018-6296-8 (2019).","journal-title":"Surg. Endosc."},{"key":"74424_CR49","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1007\/s11605-019-04139-7","volume":"23","author":"EA Vega","year":"2019","unstructured":"Vega, E. A. et al. Preoperative prognosticators of safe laparoscopic hepatocellular carcinoma resection in advanced cirrhosis: a propensity score matching population-based analysis of 1799 western patients. J. Gastrointest. Surg. 23, 1157\u20131165. https:\/\/doi.org\/10.1007\/s11605-019-04139-7 (2019).","journal-title":"J. Gastrointest. Surg."},{"key":"74424_CR50","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0016-5107(81)73224-3","volume":"27","author":"K Beppu","year":"1981","unstructured":"Beppu, K. et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest. Endosc. 27, 213\u2013218 (1981).","journal-title":"Gastrointest. Endosc."},{"key":"74424_CR51","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.gie.2017.12.023","volume":"88","author":"PH Chen","year":"2018","unstructured":"Chen, P. H. et al. Combination of albumin-bilirubin grade and platelets to predict a compensated patient with hepatocellular carcinoma who does not require endoscopic screening for esophageal varices. Gastrointest. Endosc. 88, 230-239e232. https:\/\/doi.org\/10.1016\/j.gie.2017.12.023 (2018).","journal-title":"Gastrointest. Endosc."},{"key":"74424_CR52","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/hep.24199","volume":"53","author":"J Bruix","year":"2011","unstructured":"Bruix, J. & Sherman, M. Management of hepatocellular carcinoma: an update. Hepatology 53, 1020\u20131022. https:\/\/doi.org\/10.1002\/hep.24199 (2011).","journal-title":"Hepatology"},{"key":"74424_CR53","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000487407","volume":"7","author":"KC Fang","year":"2018","unstructured":"Fang, K. C. et al. The prognosis of single large hepatocellular carcinoma was distinct from Barcelona clinic liver cancer stage A or B: the role of albumin-bilirubin grade. Liver Cancer 7, 335\u2013358. https:\/\/doi.org\/10.1159\/000487407 (2018).","journal-title":"Liver Cancer"},{"key":"74424_CR54","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.3748\/wjg.v22.i10.2922","volume":"22","author":"ML Schilsky","year":"2016","unstructured":"Schilsky, M. L. & Moini, M. Advances in liver transplantation allocation systems. World J. Gastroenterol. 22, 2922\u20132930. https:\/\/doi.org\/10.3748\/wjg.v22.i10.2922 (2016).","journal-title":"World J. Gastroenterol."},{"key":"74424_CR55","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","volume":"33","author":"FY Yao","year":"2001","unstructured":"Yao, F. Y. et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33, 1394\u20131403. https:\/\/doi.org\/10.1053\/jhep.2001.24563 (2001).","journal-title":"Hepatology"},{"key":"74424_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo, D., Demartines, N. & Clavien, P. A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240, 205\u2013213. https:\/\/doi.org\/10.1097\/01.sla.0000133083.54934.ae (2004).","journal-title":"Ann. Surg."},{"key":"74424_CR57","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","volume":"149","author":"NN Rahbari","year":"2011","unstructured":"Rahbari, N. N. et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149, 713\u2013724. https:\/\/doi.org\/10.1016\/j.surg.2010.10.001 (2011).","journal-title":"Surgery"},{"key":"74424_CR58","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson, P. J. et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J. Clin. Oncol. 33, 550\u2013558. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151 (2015).","journal-title":"J. Clin. Oncol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74424-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74424-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74424-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T21:04:36Z","timestamp":1670360676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-74424-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["74424"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-74424-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"20 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17259"}}